Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Linghe granules (also known as Kang's Ling-He Granules) is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Xiamen Hospital of Traditional Chinese Medicine. It is specifically investigated for the treatment of metabolically associated fatty liver disease (MAFLD) and obesity-related metabolic disorders. The formulation is designed to address metabolic imbalances, aiming to reduce hepatic fat accumulation and improve liver function in obese populations. Clinical evaluation of the granules, such as those registered in the Chinese Clinical Trial Registry (ChiCTR), focuses on establishing prediction models for therapeutic efficacy and assessing changes in metabolic parameters and body composition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on linghe granules (Xiamen Hospital of Traditional Chinese Medicine).